Brokerages Expect Skylight Health Group Inc. (NASDAQ:SLHG) Will Announce Quarterly Sales of $10.52 Million

Analysts forecast that Skylight Health Group Inc. (NASDAQ:SLHGGet Rating) will announce sales of $10.52 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Skylight Health Group’s earnings, with the lowest sales estimate coming in at $9.94 million and the highest estimate coming in at $10.92 million. Skylight Health Group reported sales of $8.56 million during the same quarter last year, which indicates a positive year-over-year growth rate of 22.9%. The business is expected to announce its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Skylight Health Group will report full year sales of $47.84 million for the current fiscal year, with estimates ranging from $39.93 million to $57.95 million. For the next year, analysts anticipate that the firm will post sales of $67.32 million, with estimates ranging from $51.75 million to $91.73 million. Zacks’ sales calculations are an average based on a survey of research analysts that follow Skylight Health Group.

A number of analysts have commented on the company. Lake Street Capital reduced their price objective on Skylight Health Group from $6.00 to $3.00 in a research report on Friday, April 1st. Zacks Investment Research downgraded Skylight Health Group from a “buy” rating to a “hold” rating in a research report on Friday, April 8th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $4.44.

Institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC bought a new position in shares of Skylight Health Group during the 3rd quarter worth approximately $31,000. HighTower Advisors LLC bought a new position in Skylight Health Group in the 1st quarter valued at $63,000. Royal Bank of Canada bought a new position in Skylight Health Group in the 2nd quarter valued at $63,000. Citadel Advisors LLC bought a new position in Skylight Health Group in the 4th quarter valued at $64,000. Finally, Raymond James & Associates bought a new position in Skylight Health Group in the 1st quarter valued at $90,000. Institutional investors and hedge funds own 0.74% of the company’s stock.

SLHG opened at $0.80 on Friday. The stock’s 50 day moving average price is $0.88 and its two-hundred day moving average price is $1.08. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.56. Skylight Health Group has a 12-month low of $0.55 and a 12-month high of $6.07.

About Skylight Health Group (Get Rating)

Skylight Health Group Inc operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing.

See Also

Get a free copy of the Zacks research report on Skylight Health Group (SLHG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Skylight Health Group (NASDAQ:SLHG)

Want More Great Investing Ideas?

Receive News & Ratings for Skylight Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skylight Health Group and related companies with MarketBeat.com's FREE daily email newsletter.